Enox Biopharma, which specializes in solutions for infections associated with medical devices, has granted Ortho Dental Solutions (ODS) an exclusive royalty bearing license and rights to a patent application and know-how for use in developing novel therapies for dental and periodontal diseases.
Under the terms of the agreement, ODS will use Enox Biopharma technologies to develop an innovative treatment for periodontal disease. Enox claims that its formulation has proved to be an effective agent against a wide range of bacterial infections, and ODS will use it to develop novel products to reduce postdental treatment infections and prevent periodontal disease.
Copyright © 2011 DrBicuspid.com
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
